BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37286130)

  • 1. Cost-effectiveness of Myomectomy versus Hysterectomy in Women with Uterine Fibroids.
    Thao V; Moriarty JP; Stewart EA; Borah BJ
    J Minim Invasive Gynecol; 2023 Oct; 30(10):813-819. PubMed ID: 37286130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine artery embolisation versus myomectomy for premenopausal women with uterine fibroids wishing to avoid hysterectomy: the FEMME RCT.
    Daniels J; Middleton LJ; Cheed V; McKinnon W; Rana D; Sirkeci F; Manyonda I; Belli AM; Lumsden MA; Moss J; Wu O; McPherson K
    Health Technol Assess; 2022 Apr; 26(22):1-74. PubMed ID: 35435818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised trial of treating fibroids with either embolisation or myomectomy to measure the effect on quality of life among women wishing to avoid hysterectomy (the FEMME study): study protocol for a randomised controlled trial.
    McPherson K; Manyonda I; Lumsden MA; Belli AM; Moss J; Wu O; Middleton L; Daniels J
    Trials; 2014 Nov; 15():468. PubMed ID: 25432688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine artery embolization, hysterectomy, or myomectomy for symptomatic uterine fibroids: a cost-utility analysis.
    You JH; Sahota DS; Yuen PM
    Fertil Steril; 2009 Feb; 91(2):580-8. PubMed ID: 18295216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness of hysterectomy versus myomectomy on one-year health-related quality of life in women with uterine fibroids.
    Wallace K; Zhang S; Thomas L; Stewart EA; Nicholson WK; Wegienka GR; Wise LA; Laughlin-Tommaso SK; Diamond MP; Marsh EE; Jacoby VL; Anchan RM; Venable S; Larry GM; Lytle B; Wang T; Myers ER
    Fertil Steril; 2020 Mar; 113(3):618-626. PubMed ID: 32192594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term health-related quality of life and symptom severity following hysterectomy, myomectomy, or uterine artery embolization for the treatment of symptomatic uterine fibroids.
    Anchan RM; Spies JB; Zhang S; Wojdyla D; Bortoletto P; Terry K; Disler E; Milne A; Gargiulo A; Petrozza J; Brook O; Srouji S; Morton CC; Greenberg J; Wegienka G; Stewart EA; Nicholson WK; Thomas L; Venable S; Laughlin-Tommaso S; Diamond MP; Maxwell GL; Marsh EE; Myers ER; Vines AI; Wise LA; Wallace K; Jacoby VL
    Am J Obstet Gynecol; 2023 Sep; 229(3):275.e1-275.e17. PubMed ID: 37244458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine artery embolisation or myomectomy for women with uterine fibroids wishing to avoid hysterectomy: a cost-utility analysis of the FEMME trial.
    Rana D; Wu O; Cheed V; Middleton LJ; Moss J; Lumsden MA; McKinnon W; Daniels J; Sirkeci F; Manyonda I; Belli AM; McPherson K;
    BJOG; 2021 Oct; 128(11):1793-1802. PubMed ID: 34053154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterine-Artery Embolization or Myomectomy for Uterine Fibroids.
    Manyonda I; Belli AM; Lumsden MA; Moss J; McKinnon W; Middleton LJ; Cheed V; Wu O; Sirkeci F; Daniels JP; McPherson K;
    N Engl J Med; 2020 Jul; 383(5):440-451. PubMed ID: 32726530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of uterine leiomyomas.
    Vilos GA; Allaire C; Laberge PY; Leyland N;
    J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU) for Treatment of Symptomatic Uterine Fibroids: An Economic Analysis.
    Babashov V; Palimaka S; Blackhouse G; O'Reilly D
    Ont Health Technol Assess Ser; 2015; 15(5):1-61. PubMed ID: 26357531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uterine artery embolization for symptomatic uterine fibroids.
    Gupta JK; Sinha A; Lumsden MA; Hickey M
    Cochrane Database Syst Rev; 2014 Dec; (12):CD005073. PubMed ID: 25541260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of uterine leiomyomas.
    Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
    J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of uterine-preserving procedures for the treatment of uterine fibroid symptoms in the USA.
    Cain-Nielsen AH; Moriarty JP; Stewart EA; Borah BJ
    J Comp Eff Res; 2014 Sep; 3(5):503-14. PubMed ID: 24878319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects on heavy menstrual bleeding and pregnancy of uterine artery embolization (UAE) or myomectomy for women with uterine fibroids wishing to avoid hysterectomy: The FEMME randomized controlled trial.
    Sirkeci F; Moss J; Belli AM; McPherson K; Daniels J; Manyonda I; Middleton L; Cheed V; Wu O; Lumsden MA;
    Int J Gynaecol Obstet; 2023 Feb; 160(2):492-501. PubMed ID: 36511801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Fertility Goals on Long-term Quality of Life in Reproductive-aged Women Who Underwent Myomectomy versus Hysterectomy for Uterine Fibroids.
    Frisch EH; Mitchell J; Yao M; Llarena N; Omosigho UR; DeAngelo L; Arakelian M; Bradley L; Falcone T
    J Minim Invasive Gynecol; 2023 Aug; 30(8):642-651. PubMed ID: 37044261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of Endovascular and Surgical Treatments for Symptomatic Uterine Leiomyomas: A Population Health Perspective.
    Wang C; Kuban JD; Lee SR; Yevich S; Metwalli Z; McCarthy CJ; Sheth SA; Sheth RA
    J Vasc Interv Radiol; 2020 Oct; 31(10):1552-1559.e1. PubMed ID: 32917502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Comparing Options for Management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) registry: rationale and design.
    Stewart EA; Lytle BL; Thomas L; Wegienka GR; Jacoby V; Diamond MP; Nicholson WK; Anchan RM; Venable S; Wallace K; Marsh EE; Maxwell GL; Borah BJ; Catherino WH; Myers ER
    Am J Obstet Gynecol; 2018 Jul; 219(1):95.e1-95.e10. PubMed ID: 29750955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness of pre-operative gonadotrophin releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy.
    Farquhar C; Brown PM; Furness S
    BJOG; 2002 Nov; 109(11):1273-80. PubMed ID: 12452466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ulipristal acetate for pre-operative management of uterine fibroids: Modeling outcomes and costs.
    Badiani B; Chiumente M; Messori A
    Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():84-88. PubMed ID: 29408752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids. The HOPEFUL study.
    Hirst A; Dutton S; Wu O; Briggs A; Edwards C; Waldenmaier L; Maresh M; Nicholson A; McPherson K
    Health Technol Assess; 2008 Mar; 12(5):1-248, iii. PubMed ID: 18331704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.